Sunday, December 21, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

IDEXX Laboratories Incs Short Interest and Peer Comparison

Elaine Mendonca by Elaine Mendonca
January 12, 2024
in Breaking News
0
Biotechnology Trading online
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

IDEXX Laboratories Inc.’s (NYSE:IDXX) short interest has experienced a decline of 15.88% since its last report on January 12, 2024. The company recently disclosed that there are 1.84 million shares sold short, which represents 2.49% of all regular shares available for trading. Based on the trading volume, it would take traders an average of 6.0 days to cover their short positions.

The level of short interest in a stock is significant as it can provide insights into market sentiment towards the company. A decrease in short interest may indicate a more optimistic outlook among traders and investors.

When comparing IDEXX Laboratories’ short interest to its peers, it is worth noting that the company’s short interest is slightly higher than that of its peer group. The average short interest as a percentage of float for the peer group is 3.42%. Additionally, IDEXX Laboratories Inc.’s P/Earnings NTM ratio is considerably higher than the median of its peer group, standing at approximately 22.00.

Peer comparison is a widely used method by analysts and investors to assess a company’s performance. IDEXX Laboratories’ peer group comprises companies with similar characteristics, such as industry, size, age, and financial structure.

Considering these factors is crucial when analyzing IDEXX Laboratories’ short interest and evaluating its performance relative to its peers.

IDEXX Laboratories Inc. (IDXX) Shows Mixed Performance on January 12, 2024: Stock Remains Strong Near Top of 52-Week Range

IDEXX Laboratories Inc. (IDXX) had a mixed performance on January 12, 2024, as the stock opened lower than its previous close and experienced a slight drop in price. However, it is still trading near the top of its 52-week range and remains above its 200-day simple moving average, indicating overall positive momentum. IDXX opened at $556.69, which was $2.02 lower than its previous close. Despite the lower opening, IDXX’s price momentum remains strong. The fact that the stock is trading near the top of its 52-week range suggests that investors have been optimistic about the company’s prospects. Additionally, IDXX is trading above its 200-day simple moving average, which is a technical indicator often used to assess the long-term trend of a stock. However, it is worth noting that on January 12, 2024, IDXX shares experienced a price drop of $10.96, representing a decrease of 1.96%. Investors and analysts will likely closely monitor IDXX’s performance in the coming days to assess whether the January 12th drop was an isolated event or part of a larger trend. It will be important to consider both the company’s fundamental factors, such as financial performance and growth prospects, as well as external market conditions when evaluating the stock’s future potential.

IDXX Stock Performance on January 12, 2024: Mixed Picture with Steady Revenue but Declining Net Income and EPS

On January 12, 2024, IDXX stock experienced a mixed performance as its total revenue held steady while its net income declined. According to data sourced from CNN Money, IDXX’s total revenue for the past year stood at $3.37 billion, with a quarterly revenue of $915.53 million. Comparing these figures to the previous year, we can see that the total revenue has increased by 4.73%. However, when comparing the quarterly revenue to the previous quarter, we observe that there was no change, indicating a flat performance. While the revenue remained stable, IDXX’s net income showed a decline. The company’s net income for the past year was reported at $679.09 million, with a quarterly net income of $212.23 million. This signifies a decrease of 8.83% since the previous year. Additionally, when comparing the quarterly net income to the previous quarter, we note a decline of 5.35%. Furthermore, the earnings per share (EPS) for IDXX also experienced a decrease. The EPS for the past year was $8.03, while the quarterly EPS was $2.53. This translates to a decrease of 6.7% since the previous year. Additionally, when comparing the quarterly EPS to the previous quarter, we observe a decline of 5.36%. These figures suggest a mixed performance for IDXX on January 12, 2024. It is important to note that these figures represent a snapshot of the company’s financials on a specific date and should not be considered as the sole indicator of its overall performance. Investors and analysts will likely scrutinize these numbers to assess the factors contributing to the decline in net income and EPS. They may investigate the company’s cost structure, sales performance, and market conditions to gain insights into the underlying reasons for these declines. It is crucial for investors to consider these financial metrics in conjunction with other qualitative and quantitative factors before making any investment decisions. Conducting thorough research and seeking professional advice can help investors navigate the complexities of the stock market and make informed choices. Overall, IDXX’s stock performance on January 12, 2024, showed a mixed picture with steady revenue but declining net income and EPS. Investors will closely monitor future financial reports to gauge the company’s ability to reverse these negative trends and drive sustainable growth.

Tags: IDXX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Finance_Commercial (2)

Title The Rise in Short Interest and Peer Comparison Assessing Newmonts Market Standing

Revolutionizing Industrial Packaging Greif Inc and IonKrafts Sustainable Collaboration

Finance_ stocks to buy

Alicos Dividend Strategy and Financial Challenges

Recommended

JD.com Stock

Pivotal Week Ahead for JD.com as Major European Acquisition and EV Launch Converge

2 months ago
Snowflake Stock

Snowflake Faces Investor Confidence Test After Executive’s Rogue Forecast

2 months ago
Fiserv Stock

Fiserv’s Strategic Expansion Meets Legal Scrutiny

3 months ago
Does_Walmart_Take_Google_Pay

Does Walmart Take Google Pay? Exploring Walmart’s Exclusive Payment Solution

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Bitcoin Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

Strategy Inc. Faces a Critical Index Classification Decision

DeFi Technologies Broadens Global Reach with New Listings and Products

Barrick Gold Secures Key Resolution in Mali, Paving Way for Mine Restart

Analyst Upgrade Sends Red Cat Shares Soaring

A Billion-Dollar Vote of Confidence for Standard Lithium

Trending

Tesla Stock
Automotive & E-Mobility

Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push

by Dieter Jaworski
December 21, 2025
0

Tesla shares are trading near their 52-week high as the company approaches a pivotal week, fueled by...

Wolfspeed Stock

Wolfspeed Secures Financial and Strategic Milestones

December 21, 2025
Textron Stock

Textron Stock Approaches Annual Peak Amid Strategic Wins

December 21, 2025
Intellia Therapeutics Stock

Intellia Therapeutics Faces Mounting Analyst Scrutiny Amid Regulatory Setback

December 21, 2025
Strategy Stock

Strategy Inc. Faces a Critical Index Classification Decision

December 21, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Tesla’s Valuation Faces Crucial Test Amid Legal Victory and Robotaxi Push
  • Wolfspeed Secures Financial and Strategic Milestones
  • Textron Stock Approaches Annual Peak Amid Strategic Wins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com